Review article · 2026 · Open access

CAR-T cell therapy: A new dawn in the treatment of autoimmune disease

Sijia Yan, Xiaojian Zhu, Yi Xiao

Cell Transplantation, 35, 9636897251414211 · Published 1 January 2026 · DOI 10.1177/09636897251414211

Open full textCite this paper

In brief

“CAR-T cell therapy: A new dawn in the treatment of autoimmune disease” is a 2026 review article by Sijia Yan and 2 co-authors, published in Cell Transplantation. OpenAlex counts 1 citations as of 20 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Cell Transplantation.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
0.67
References
98
Authors
3

Abstract

Autoimmune diseases (AIDs) are a class of diseases caused by autoimmune intolerance, which can be divided into systemic and organ-specific diseases. AIDs affect approximately 10% of the global population and rank among the leading causes of disability and mortality. At present, immunosuppressive agents are the first choice for the treatment of AIDs. B-cell-targeted therapies-particularly CD20 monoclonal antibodies-have brought new hope for systemic AIDs, yet a subset of patients still respond poorly. As a rapidly developing cellular immunotherapy technology, Chimeric antigen receptor T cell (CAR-T) plays an important role in the treatment of hematological malignancies. CAR-T targeting B-cell-specific antigens can rapidly deplete circulating B cells, thereby reducing the formation of autoantibodies, which has become the basis for research on CAR-T in the treatment of autoimmune diseases. Currently, many studies are underway, and CAR-T and its derivative therapies bring new hope for the treatment of autoimmune diseases.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Yan, S., Zhu, X., & Xiao, Y. (2026). CAR-T cell therapy: A new dawn in the treatment of autoimmune disease. Cell Transplantation, 35, 9636897251414211. https://doi.org/10.1177/09636897251414211

MLA 9

Yan, Sijia, et al. “CAR-T cell therapy: A new dawn in the treatment of autoimmune disease.” Cell Transplantation, vol. 35, 2026, p. 9636897251414211. https://doi.org/10.1177/09636897251414211.

Chicago

Yan, Sijia, Xiaojian Zhu, and Yi Xiao. 2026. “CAR-T cell therapy: A new dawn in the treatment of autoimmune disease.” Cell Transplantation 35: 9636897251414211. https://doi.org/10.1177/09636897251414211.

Harvard

Yan, S., Zhu, X. and Xiao, Y. (2026) ‘CAR-T cell therapy: A new dawn in the treatment of autoimmune disease’, Cell Transplantation, 35, p. 9636897251414211. doi:10.1177/09636897251414211.

IEEE

S. Yan, X. Zhu, and Y. Xiao, “CAR-T cell therapy: A new dawn in the treatment of autoimmune disease,” Cell Transplantation, vol. 35, p. 9636897251414211, 2026, doi: 10.1177/09636897251414211.

BibTeX

@article{yan2026cell,
  title     = {{CAR-T cell therapy: A new dawn in the treatment of autoimmune disease}},
  author    = {Yan, Sijia and Zhu, Xiaojian and Xiao, Yi},
  journal   = {Cell Transplantation},
  year      = {2026},
  volume    = {35},
  pages     = {9636897251414211},
  doi       = {10.1177/09636897251414211},
  url       = {https://doi.org/10.1177/09636897251414211}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › CAR-T cell therapy research

  • CAR T-cell therapy
  • chimeric antigen receptor T cells
  • autoimmune disease
  • B-cell depletion
  • autoantibodies
  • systemic autoimmune diseases
  • organ-specific autoimmune diseases
  • anti-CD20 monoclonal antibody

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Yan, S., Zhu, X., & Xiao, Y. (2026). CAR-T cell therapy: A new dawn in the treatment of autoimmune disease. Cell Transplantation, 35, 9636897251414211. https://doi.org/10.1177/09636897251414211

How many times has this paper been cited?

1 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Cell Transplantation: sign in and open the full text from this page.

Who wrote this paper?

Sijia Yan, Xiaojian Zhu, Yi Xiao.

What is the DOI of this paper?

10.1177/09636897251414211, permanently at https://doi.org/10.1177/09636897251414211. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.